|
Quotes & Info
|
| ANX > SEC Filings for ANX > Form 8-K on 7-Dec-2012 | All Recent SEC Filings |
7-Dec-2012
Change in Directors or Principal Officers, Financial Statements and
On December 6, 2012, the Compensation Committee (the "Committee") of the Board of Directors (the "Board") of ADVENTRX Pharmaceuticals, Inc. (the "Company") adopted the ADVENTRX Pharmaceuticals, Inc. Change in Control Severance Plan (the "Plan") and designated certain company officers, including Gregory D. Gorgas, one of the Company's named executive officers (as identified in the Company's proxy statement relating to the Company's 2012 annual meeting of stockholders) as participants in the Plan. The Board may amend or terminate the Plan at any time provided that any such amendment or termination will not take effect earlier than 12 months following the date the amendment or termination is adopted by the Board without the written consent of the affected participant.
Under the Plan, if a participant's employment with the Company terminates as a result of an Involuntary Termination during the period commencing three months prior to and ending on the one-year anniversary of a Change in Control, and the participant timely delivers and does not revoke a general release of claims against the Company, then the participant shall be entitled to severance benefits consisting of: (a) a lump sum payment in an amount equal to six or nine months (the "Benefit Period") of the participant's annual base salary in effect at the time of the eligible termination, with the number of months applicable to each participant determined by the Committee in the case of "officers" of the Company (as defined in Rule 16a-1(f) of the Exchange Act) and by the Company's Chief Executive Officer or the Company's President in the case of all other employees; and (b) a lump sum payment in an amount equal to the estimated cost of continuing the participant's health care coverage and the coverage of the participant's dependents who are covered at the time of the eligible termination under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, for the Benefit Period. The Compensation Committee assigned a nine-month Benefit Period to Mr. Gorgas.
In summary, for purposes of the Plan:
• "Involuntary Termination" means the termination of the employment of a
participant by the Company without Cause or by the participant for Good Reason;
• "Cause" means (i) any act of personal dishonesty taken by the participant in
connection with his or her responsibilities as an employee which is intended to
result in substantial personal enrichment of the participant; (ii) the
participant's conviction of a felony that the Board reasonably believes has had
or will have a material detrimental effect on the Company's reputation or
business; (iii) a willful act by the participant that constitutes misconduct and
is materially injurious to the Company; or (iv) continued willful violations by
the participant of the participant's obligations to the Company after there has
been delivered to the participant a written demand for performance from the
Company that describes the basis for the Company's belief that the participant
has not substantially performed his or her duties;
• "Good Reason" means (i) without the participant's express written consent, a
material reduction or alteration of the participant's duties, position or
responsibilities relative to the participant's duties, position or
responsibilities in effect immediately prior to such reduction or alteration, or
the removal of the participant from such position, duties or responsibilities;
(ii) without the participant's express written consent, a material reduction by
the Company of the participant's base salary as in effect immediately prior to
such reduction; (iii) without the participant's express written consent, the
relocation of the participant's principal place of employment with the Company
by more than 50 miles; or (iv) a material breach of the Plan, including, but not
limited to the failure of the Company to obtain the assumption of the Plan by
any successor; and
• "Change in Control" means (i) certain changes during any 24-month period in
individuals constituting a majority of the Board; (ii) certain acquisitions of
securities of the Company representing 30% or more of the combined voting power
of the Company's then outstanding securities eligible to vote for the election
of the Board, other than by the Company or any subsidiary, any employee benefit
plan sponsored or maintained by the Company or any subsidiary, any underwriter
temporarily holding securities pursuant to an offering of such securities, or
any person whose acquisition of such securities is less than 50% and is approved
in advance by a majority of the incumbent Board; (iii) the consummation of
certain mergers, consolidations, statutory share exchanges, or similar forms of
corporate transactions involving the Company or any of its subsidiaries that
require the approval of the Company's stockholders, whether for such transaction
or the issuance of securities in the transaction; or (iv) approval by the
Company's stockholders of a plan of complete liquidation or dissolution of the
Company or the sale of all or substantially all of the Company's assets.
Notwithstanding the foregoing, a "change in control" shall not be deemed to have
occurred if, immediately following the triggering transaction, (A) more than 50%
of the total voting power of surviving corporation (or, if applicable, of a
parent corporation of the surviving corporation that holds at least 90% of the
voting securities of the surviving corporation) is represented by voting
securities of the Company that were outstanding immediately prior to the
transaction and such securities are held in substantially the same proportion as
immediately prior to the transaction, (B) no person becomes the beneficial owner
of 30% or more of the total voting power of the outstanding securities eligible
to elect directors of the surviving corporation (or its parent corporation, as
applicable); and (C) at least a majority of the members of the board of
directors of the surviving corporation (or its parent corporation, as
applicable) were incumbent members of the Board at the time of the Board's
approval of the transaction.
The foregoing description of the terms of the Plan is subject to, and qualified in its entirety by, the Plan, which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
(d) Exhibits.
The list of exhibits called for by this Item is incorporated by reference to the Exhibit Index filed with this report.
|
|